NCT00219258View on ClinicalTrials.gov

Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma

PHASE3CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

July 31, 2005

Conditions

Treatment of Bone Metastases

Interventions

DRUG

Zoledronic acid

Trial Locations (1)

Unknown

Beijing, Beijing

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY